Mylan N.V. is an American global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and global headquarters in Canonsburg, Pennsylvania, US. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, Mylan grew from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.
In 2016, Mylan's pricing of the EpiPen, an epinephrine autoinjector, became controversial and was widely referred to as "price gouging". As a result, investigations were opened into whether Mylan had misclassified the EpiPen under the Medicaid Drug Rebate Program, a common form of pharmaceutical fraud. In October 2016, Mylan settled these investigations with the U.S. Department of Justice, agreeing to pay $465 million and enter into a corporate integrity agreement concerning the rebate program.
|Traded as||NASDAQ: MYL TASE: MYL NASDAQ Biotechnology Component NASDAQ-100 Component S&P 500 Component|
|Founded||1961; 56 years ago (1961) in White Sulphur Springs, West Virginia, United States|
|Products||Generic and specialty pharmaceuticals and active pharmaceutical ingredients|
|Headquarters||Canonsburg, Pennsylvania, United States of America|
|Total assets||US$ 22.267 billion (2015)|
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Yes, it is.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Major Pharmaceuticals is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If Mylan N.V. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of Mylan N.V. with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
|DirecTV||Telecommunications / Cable/TV service||12|
|MTV||Consumer Brands / Entertainment||12|
|AXA||Financial Services / Banking||12|
|Showtime||Consumer Brands / Entertainment||11|
|KPN||Telecommunications / Wireless Carrier||11|
|Blockbuster on Demand||Consumer Brands / Entertainment||11|
|Consumer Brands / Internet||11|
|Netflix||Consumer Brands / Entertainment||13|
|TD Bank||Financial Services / Banking||10|
|Liberty Mutual||Insurance / Health and Life Insurance||14|
We have estimated the Net Promoter Score of Mylan N.V. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.